Results from the PRECISE trial, first discussed at the SCAI Scientific Sessions in 2012, were published in the Journal of the American College of Cardiology. Interventional cardiologists who used the CorPath 200 robotic system to perform percutaneous coronary interventions on 164 patients reported clinical procedural success in 97.6% of cases, while decreasing operators' radiation exposure by 95%. The robot-enhanced PCI system also is expected to reduce the orthopedic and eye problems commonly suffered by interventional cardiologists, researchers noted.

Full Story:

Related Summaries